Li-Xin Cheng

Integrative Inflammation–Metabolism Indicator for Cardiovascular–Kidney–Metabolic Syndrome: Evaluating the C‐Reactive Protein–Triglyceride Glucose Index for Risk Stratification and Progression Across Three National Cohorts

CTI emerged as the most robust inflammatory biomarker for assessing disease severity and predicting CKM progression among multiple candidates, and its reproducible associations across national cohorts support its utility for early detection and risk stratification.